Chester County News and Community Website
WASHINGTON, D.C. — As part of President Trump’s Executive Order No. 14273, Lowering Drug Prices by Once Again Putting Americans First, the FTC, DOJ Antitrust Division, Department of Commerce, and …
FTC and DOJ Host Listening Sessions to Lower Drug Prices and Boost Competition Read More
CLAYMONT, DE — ReflexMD has officially launched its nationwide online platform, providing patients with a streamlined way to consult with licensed healthcare providers and access prescription medications. The service is …
ReflexMD Launches Nationwide Online Service for Convenient Healthcare Read More
WASHINGTON, D.C. — The Federal Trade Commission (FTC) has escalated its efforts to address improper patent listings that hinder generic competition and keep drug prices high. On May 21, the …
FTC Renews Challenges Against Improper Patent Listings to Combat High Drug Prices Read More
HARRISBURG, PA — Attorney General Michelle Henry has announced the sentencing of Joseph G. Sapp, a former certified registered nurse practitioner from western Pennsylvania, to 11.5 to 23 months in …
Oxycodone Scandal: Ex-Nurse Practitioner Faces Justice in Shocking Prescription Fraud Case! Read More
WASHINGTON, D.C. — In a move to address escalating insulin prices, the Federal Trade Commission (FTC) has initiated action against the three largest prescription drug benefit managers (PBMs) in the …
FTC Takes Bold Stand: Major PBMs Face Scrutiny Over Inflated Insulin Prices! Read More
WASHINGTON, D.C. — In a revealing new interim report, the Federal Trade Commission (FTC) has raised the alarm on the powerful influence Pharmacy Benefit Managers (PBMs) wield over the American …
Big Pharma’s Puppet Masters: How PBMs Dictate Prescription Drug Accessibility Read More WASHINGTON, D.C. — The Federal Trade Commission (FTC) recently applauded the National Institute of Standards and Technology (NIST) for its draft framework to guide the federal government’s use of “march-in” …
FTC Backs Federal ‘March-In’ Rights to Curb High Drug Prices Read More
The U.S. Food and Drug Administration (FDA) recently authorized Florida’s Agency for Health Care Administration to import certain prescription drugs from Canada under section 804 of the Federal Food, Drug, …
Florida Gets Green Light from FDA to Import Prescription Drugs from Canada: A Potential Game-Changer for U.S. Healthcare Costs Read More
The Federal Trade Commission (FTC) has recently finalized a consent order that resolves potential competition issues arising from Amgen Inc.’s acquisition of Horizon Therapeutics plc. This follows the dismissal of …
FTC Finalizes Consent Order in Amgen’s Acquisition of Horizon Therapeutics, Ensuring Continued Pharmaceutical Competition Read More
The Federal Trade Commission (FTC) recently announced that it has moved to dismiss its case against pharmaceutical giant Sanofi following the company’s decision to terminate its proposed acquisition of an …
FTC Dismisses Case Against Sanofi After Termination of Proposed Acquisition of Pompe Disease Drug License from Maze Therapeutics Read More